Replies to post #10921 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

Why are they saying after 3 years of testing by BioCurex?

"as the press release states that more than three years of testing by BioCurex has confirmed RECAF's high degree of clinical sensitivity and specificity in detecting various types of cancer, even when the disease is at its earliest stage. RECAF (the receptor for alpha-fetoprotein) is a wide-spectrum marker present in malignant cancer cells and absent in most normal cells, allowing it to play a major role in the development of new diagnostic tests for prostate, breast, colorectal, lung and other cancers."

They have been testing and gathering data for Recaf for close to 10 years when the company started in 1997.
They should have also said that we have validated data by independant labs and scientists in and outside of the US where we hold 22 patents.

[doggone01]

Thanks Dakota at best the news is getting out to wall street anyway.We need all the press we can get.